Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
about
Nano-gold corking and enzymatic uncorking of carbon nanotube cupsNovel formulations for antimicrobial peptidesImproving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survivalVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmOptical imaging probes in oncologySapC-DOPS nanovesicles as targeted therapy for lung cancerQuantitative Analysis of the Enhanced Permeation and Retention (EPR) EffectSonoporation enhances liposome accumulation and penetration in tumors with low EPR.Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?Photoacoustic Brain Imaging: from Microscopic to Macroscopic ScalesShort-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.The Theranostic Path to Personalized NanomedicineEnhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors.Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cellsNanotechnology for the treatment of melanoma skin cancer.Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicinState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesChemical glycosylation of cytochrome c improves physical and chemical protein stability.Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncologyCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerCancer drug delivery: considerations in the rational design of nanosized bioconjugates.Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study.In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myelomaBiodistribution of P-selectin targeted microbubbles.Pushing the optical imaging limits of cancer with multi-frequency-band raster-scan optoacoustic mesoscopy (RSOM)Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical TranslationThe cytotoxicity of BAMLET complexes is due to oleic acid and independent of the α-lactalbumin component.Nanotechnology for cancer treatment.Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity.Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity.Multistage vector (MSV) therapeutics.An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors.Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.Non-affinity factors modulating vascular targeting of nano- and microcarriersMolecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.
P2860
Q23924065-508E2F49-58E0-4172-9C14-C39772461038Q26991771-3E4B0FAD-9A3A-4B1B-B47E-E5DFFBC726D8Q26999332-DA658EF0-CAAF-47A3-9B5D-1B389A7816ABQ27023583-02C26F66-F47E-4F70-B388-ED99EB234BB3Q27026630-32B8D6F5-089A-4E94-A9A1-C63D014AAA8BQ28067824-F4E5E622-59B2-4100-A8BC-CF0A0C931D58Q28387728-50D3576E-75A9-4505-BBAF-27B696AEB684Q28547003-787FF576-6612-402A-8A5B-FABB04D50B27Q30358121-8B0C77A9-5C19-41B1-8B88-F8C20A60B4DBQ30360668-179DC362-FBDC-4BCF-A10F-0E5CD6AA9170Q30426250-9C21166F-CF0B-4F1F-A0C7-E6CE044680A6Q30429246-5FD0FD33-18BC-43AF-9B8B-25E0FFD13E47Q30437998-EC5F08FB-5BAF-4ECF-80ED-D277213708FFQ31146684-F60F8ECC-8518-4DF6-883A-427471D263B6Q33629980-7A3F22BA-647E-4A17-B192-04AE2B36315DQ33670961-ABD1B43A-5942-48C2-902A-EE390704E618Q33694294-A2B11F70-C931-4176-97B1-908E1C1F713AQ33807144-0094DEEA-3DA5-49F9-BA38-D51926032F19Q34045119-9EF1513D-BC94-45A8-9A85-934BFFC131FAQ34062756-10485827-4FB9-4CC3-A3E2-8B6523EFBB2FQ34328650-AEAB37D6-310D-46F3-BBE1-63878028B294Q34447986-6FECE349-1264-4EEF-B29D-B36FFD5EBFBBQ34674722-E9F9110F-1F24-4E5C-A8C2-977CF087D976Q34764424-F1B94065-D6FD-4A19-B424-0A49C31B3DCDQ34791325-9D7E51C4-27BD-4AD2-B5E8-579CC5FABA08Q35108549-B15D8D0E-D40A-476B-8096-673F5B6E1946Q35151455-34A47AFC-3E6D-4641-B680-647942F5DC15Q35152546-70DA62B2-0626-4E38-83B5-147859F864C5Q35241339-4A6771AE-0837-4265-84F4-C04AFC62E80BQ35438759-CE19425A-CD73-4F1C-B3C3-5FCBD19FBF8DQ35603416-E32C6486-249B-4945-88C5-1D83572A47ECQ35737878-20474195-E33E-455D-BE1F-C6FB7F7A6DAEQ35918821-97229A23-59E8-4903-BFFC-F0EE8F5F2367Q35972322-8ECBD58E-9B8B-40AD-B513-0998B755E53EQ36217155-BD60C7C9-D77D-4740-8122-E8488B18B7A7Q36307634-46FF5B94-519A-41A5-835B-F682D4ABB15BQ36596242-C049CE7E-EADC-4E3F-8682-A30B475CC6F8Q36651667-88CBAFC3-5841-45FB-A3FC-27D4B0811F8FQ36703526-FAFEA4E8-8712-493E-97E0-72CE9CFE8C21Q36865064-93FBFA6E-5904-4FF9-B75F-369BBFC37971
P2860
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@ast
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@en
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@nl
type
label
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@ast
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@en
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@nl
prefLabel
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@ast
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@en
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@nl
P3181
P1476
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond
@en
P2093
Hiroshi Maeda
P304
P3181
P356
10.1016/J.JCONREL.2012.04.038
P407
P577
2012-12-10T00:00:00Z